Study of quality of life in chronic Spontaneous Urticaria patients and treated by omalizumab (Xolair®) Etude de qualité de vie chez les patients souffrant d'urticaire chronique spontanée et trai...

Update Il y a 4 ans
Reference: EUCTR2014-005424-97

Study of quality of life in chronic Spontaneous Urticaria patients and treated by omalizumab (Xolair®) Etude de qualité de vie chez les patients souffrant d'urticaire chronique spontanée et traités par omalizumab (Xolair®)

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

Evaluate the proportion of patients achieving disease control (urticaria control test [UCT] score of greater than or equal to 12) at Week 12 in adult patients with CSU with inadequate response to H1 antihistamine treatment and treated by omalizumab 300 mg S.C. every 4 weeks


Inclusion criteria

  • CHRONIC SPONTANEOUS URTICARIA

Links